Literature DB >> 21397314

A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.

Hugh A Sampson, Donald Y M Leung, A Wesley Burks, Gideon Lack, Sami L Bahna, Stacie M Jones, Dennis A Wong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21397314     DOI： 10.1016/j.jaci.2011.01.051

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  68 in total

Review 1.  Future therapies for food allergies.

Authors:  Anna Nowak-Węgrzyn; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2011-01-31       Impact factor: 10.793

Review 2.  The future of food allergy therapeutics.

Authors:  Michele Henson; A Wesley Burks
Journal:  Semin Immunopathol       Date:  2012-06-27       Impact factor: 9.623

3.  Designer covalent heterobivalent inhibitors prevent IgE-dependent responses to peanut allergen.

Authors:  Peter E Deak; Baksun Kim; Amina Abdul Qayum; Jaeho Shin; Girish Vitalpur; Kirsten M Kloepfer; Matthew J Turner; Neal Smith; Wayne G Shreffler; Tanyel Kiziltepe; Mark H Kaplan; Basar Bilgicer
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-08       Impact factor: 11.205

4.  A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.

Authors:  Lynda C Schneider; Rima Rachid; Jennifer LeBovidge; Emily Blood; Mudita Mittal; Dale T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2013-10-28       Impact factor: 10.793

Review 5.  Off-Label Uses of Omalizumab.

Authors:  David El-Qutob
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

6.  Safety, clinical, and immunologic efficacy of a Chinese herbal medicine (Food Allergy Herbal Formula-2) for food allergy.

Authors:  Julie Wang; Stacie M Jones; Jacqueline A Pongracic; Ying Song; Nan Yang; Scott H Sicherer; Melanie M Makhija; Rachel G Robison; Erin Moshier; James Godbold; Hugh A Sampson; Xiu-Min Li
Journal:  J Allergy Clin Immunol       Date:  2015-06-01       Impact factor: 10.793

Review 7.  Current opinion and review on peanut oral immunotherapy.

Authors:  Sharon Deol; J Andrew Bird
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 8.  Novel approaches to food allergy.

Authors:  Yao-Hsu Yang; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2014-06       Impact factor: 8.667

Review 9.  Use of omalizumab in the treatment of food allergy and anaphylaxis.

Authors:  Jay A Lieberman; Mirna Chehade
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

10.  Food allergy: recent advances in pathophysiology and treatment.

Authors:  Julie Wang; Hugh A Sampson
Journal:  Allergy Asthma Immunol Res       Date:  2009-09-25       Impact factor: 5.764
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.